Skip to main content

Advertisement

SpringerLink
Log in

Follow-up strategies in head and neck cancer other than upper aerodigestive tract squamous cell carcinoma

  • Review Article
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Post-therapy follow-up for patients with head and neck cancer other than upper aerodigestive tract squamous cell carcinoma should meet several objectives: to detect both local, regional or distant recurrences, to evaluate acute and long-term treatment-related side effects, to guide the rehabilitation process, and to provide psychosocial support when needed. To our knowledge, there are no published reports in the literature dedicated to the follow-up of patients with these tumours. A comprehensive literature search for post-treatment follow-up strategies spanning from 1980 to 2012 was performed on several databases. This review focuses on malignant salivary gland tumors, soft tissue sarcomas, cutaneous squamous cell carcinomas, and sinonasal adenocarcinomas. Given the varying biological behavior and treatment-related factors and based on the literature, different recommendations are made on the follow-up of patients with the above-mentioned tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108

    Article  PubMed  Google Scholar 

  2. Barnes L, Eveson JW, Reichart P, Sidransky D (2005) World Health Organization classification of tumours. Pathology and genetics of head and neck tumours. IARC Press, Lyon, pp 227–228

    Google Scholar 

  3. Berrino F, De Angelis R, Sant M et al (2007) Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–99: results of the EUROCARE-4 study. Lancet Oncol 8:773–783

    Article  PubMed  Google Scholar 

  4. Gillespie MB, Albergotti WG, Eisele DW (2012) Recurrent salivary gland cancer. Curr Treat Options Oncol 13:58–70

    Article  PubMed  Google Scholar 

  5. Seifert G, Brocheriou C, Cardesa A, Eveson JW (1990) WHO international histological classification of tumours. Tentative histological classification of salivary gland tumours. Pathol Res Pract 186:555–581

    Article  PubMed  CAS  Google Scholar 

  6. Vander Poorten V, Hart A, Vauterin T et al (2009) Prognostic index for patients with parotid carcinoma: international external validation in a Belgian–German database. Cancer 115:540–550

    Article  Google Scholar 

  7. Guzzo M, Locati LD, Prott FJ, Gatta G, McGurk M, Licitra L (2010) Major and minor salivary gland tumors. Crit Rev Oncol Hematol 74:134–148

    Article  PubMed  Google Scholar 

  8. NCCN clinical practice guidelines in oncology (NCCN Guidelines). 2012. www.nccn.org

  9. Terhaard CH, Lubsen H, Van der Tweel I et al (2004) Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group. Head Neck 26:681–692 (discussion 692–693)

    Article  PubMed  Google Scholar 

  10. van der Putten L, de Bree R, Plukker JT et al (2006) Permanent unilateral hearing loss after radiotherapy for parotid gland tumors. Head Neck 28:902–908

    Article  PubMed  Google Scholar 

  11. Erovic BM, Schopper C, Pammer J et al (2010) Multimodal treatment of patients with minor salivary gland cancer in the case of recurrent disease. Head Neck 32:1167–1172

    Article  PubMed  Google Scholar 

  12. Bell RB, Dierks EJ, Homer L, Potter BE (2005) Management and outcome of patients with malignant salivary gland tumors. J Oral Maxillofac Surg 63:917–928

    Article  PubMed  Google Scholar 

  13. Burke CJ, Thomas RH, Howlett D (2011) Imaging the major salivary glands. Br J Oral Maxillofac Surg 49:261–269

    Article  PubMed  CAS  Google Scholar 

  14. Shah GV (2002) MR imaging of salivary glands. Magn Reson Imaging Clin N Am 10:631–662

    Article  PubMed  Google Scholar 

  15. Kobayashi K, Nakao K, Yoshida M et al (2009) Recurrent cancer of the parotid gland: how well does salvage surgery work for locoregional failure? ORL J Otorhinolaryngol Relat Spec 71:239–243

    Article  PubMed  Google Scholar 

  16. Pederson AW, Haraf DJ, Blair EA et al (2010) Chemoreirradiation for recurrent salivary gland malignancies. Radiother Oncol 95:308–311

    Article  PubMed  CAS  Google Scholar 

  17. Otsuka H, Graham MM, Kogame M, Nishitani H (2005) The impact of FDG-PET in the management of patients with salivary gland malignancy. Ann Nucl Med 19:691–694

    Article  PubMed  Google Scholar 

  18. Cermik TF, Mavi A, Acikgoz G, Houseni M, Dadparvar S, Alavi A (2007) FDG PET in detecting primary and recurrent malignant salivary gland tumors. Clin Nucl Med 32:286–291

    Article  PubMed  Google Scholar 

  19. Locati LD, Guzzo M, Bossi P et al (2005) Lung metastasectomy in adenoid cystic carcinoma (ACC) of salivary gland. Oral Oncol 41:890–894

    Article  PubMed  Google Scholar 

  20. Pogodzinski MS, Sabri AN, Lewis JE, Olsen KD (2006) Retrospective study and review of polymorphous low-grade adenocarcinoma. Laryngoscope 116:2145–2149

    Article  PubMed  Google Scholar 

  21. Weber RS, Benjamin RS, Peters LJ, Ro JY, Achon O, Goepfert H (1986) Soft tissue sarcomas of the head and neck in adolescents and adults. Am J Surg 152:386–392

    Article  PubMed  CAS  Google Scholar 

  22. Zagars GK, Ballo MT, Pisters PW et al (2003) Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1,225 patients. Cancer 97:2530–2543

    Article  PubMed  Google Scholar 

  23. de Bree R, van der Waal I, de Bree E, Leemans CR (2010) Management of adult soft tissue sarcomas of the head and neck. Oral Oncol 46:786–790

    Article  PubMed  Google Scholar 

  24. Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS (2003) Prognostic factors for disease-specific survival after first relapse of soft-tissue sarcoma: analysis of 402 patients with disease relapse after initial conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys 57:739–747

    Article  PubMed  Google Scholar 

  25. Sobin LH, Wittekind CH (eds) (1997) UICC TNM classification of malignant tumours, ed 5. Wiley, New York, pp 101–109

    Google Scholar 

  26. Shah J, Patel S (2001) Atlas of clinical oncology-cancer of the head and neck: soft tissue and bone tumour. BC Decker Inc, Hamilton, pp 309–329

    Google Scholar 

  27. Van Damme JP, Schmitz S, Machiels JP et al (2010) Prognostic factors and assessment of staging systems for head and neck soft tissue sarcomas in adults. Eur J Surg Oncol 36:684–690

    Article  PubMed  Google Scholar 

  28. Pellitteri PK, Ferlito A, Bradley PJ, Shaha AR, Rinaldo A (2003) Management of sarcomas of the head and neck in adults. Oral Oncol 39:2–12

    Article  PubMed  Google Scholar 

  29. Whooley BP, Mooney MM, Gibbs JF, Kraybill WG (1999) Effective follow-up strategies in soft tissue sarcoma. Semin Surg Oncol 17:83–87

    Article  PubMed  CAS  Google Scholar 

  30. Kane JM 3rd (2004) Surveillance strategies for patients following surgical resection of soft tissue sarcomas. Curr Opin Oncol 16:328–332

    Article  PubMed  Google Scholar 

  31. Whooley BP, Gibbs JF, Mooney MM, McGrath BE, Kraybill WG (2000) Primary extremity sarcoma: what is the appropriate follow-up? Ann Surg Oncol 7:9–14

    Article  PubMed  CAS  Google Scholar 

  32. Wanebo HJ, Koness RJ, MacFarlane JK et al (1992) Head and neck sarcoma: report of the Head and Neck Sarcoma Registry. Society of Head and Neck Surgeons Committee on Research. Head Neck 14:1–7

    Article  PubMed  CAS  Google Scholar 

  33. Abatzoglou S, Turcotte RE, Adoubali A, Isler MH, Roberge D (2010) Local recurrence after initial multidisciplinary management of soft tissue sarcoma: is there a way out? Clin Orthop Relat Res 468:3012–3018

    Article  PubMed  Google Scholar 

  34. Kowalski LP, San CI (1994) Prognostic factors in head and neck soft tissue sarcomas: analysis of 128 cases. J Surg Oncol 56:83–88

    Article  PubMed  CAS  Google Scholar 

  35. Farhood AI, Hajdu SI, Shiu MH, Strong EW (1990) Soft tissue sarcomas of the head and neck in adults. Am J Surg 160:365–369

    Article  PubMed  CAS  Google Scholar 

  36. Arya S, Nagarkatti DG, Dudhat SB, Nadkarni KS, Joshi MS, Shinde SR (2000) Soft tissue sarcomas: ultrasonographic evaluation of local recurrences. Clin Radiol 55:193–197

    Article  PubMed  CAS  Google Scholar 

  37. Choi H, Varma DG, Fornage BD, Kim EE, Johnston DA (1991) Soft-tissue sarcoma: MR imaging vs sonography for detection of local recurrence after surgery. AJR Am J Roentgenol 157:353–358

    Article  PubMed  CAS  Google Scholar 

  38. Fleming JB, Cantor SB, Varma DG et al (2001) Utility of chest computed tomography for staging in patients with T1 extremity soft tissue sarcomas. Cancer 92:863–868

    Article  PubMed  CAS  Google Scholar 

  39. Shuman AG, Light E, Olsen SH et al (2011) Mucosal melanoma of the head and neck: predictors of prognosis. Arch Otolaryngol Head Neck Surg 137:331–337

    Article  PubMed  Google Scholar 

  40. Patel SG, Prasad ML, Escrig M et al (2002) Primary mucosal malignant melanoma of the head and neck. Head Neck 24:247–257

    Article  PubMed  Google Scholar 

  41. Yanagi T, Mizoe JE, Hasegawa A et al (2009) Mucosal malignant melanoma of the head and neck treated by carbon ion radiotherapy. Int J Radiat Oncol Biol Phys 74:15–20

    Article  PubMed  Google Scholar 

  42. Gavriel H, McArthur G, Sizeland A, Henderson M (2011) Review: mucosal melanoma of the head and neck. Melanoma Res 21:257–266

    Article  PubMed  Google Scholar 

  43. Goldsmith HS (1979) Melanoma: an overview. CA Cancer J Clin 29:194–215

    Article  PubMed  CAS  Google Scholar 

  44. Lee CC, Faries MB, Wanek LA, Morton DL (2009) Improved survival for stage IV melanoma from an unknown primary site. J Clin Oncol 27:3489–3495

    Article  PubMed  Google Scholar 

  45. Lentsch EJ, Myers JN (2001) Melanoma of the head and neck: current concepts in diagnosis and management. Laryngoscope 111:1209–1222

    Article  PubMed  CAS  Google Scholar 

  46. Romano E, Scordo M, Dusza SW, Coit DG, Chapman PB (2010) Site and timing of first relapse in stage III melanoma patients: implications for follow-up guidelines. J Clin Oncol 28:3042–3047

    Article  PubMed  Google Scholar 

  47. Livingstone E, Windemuth-Kieselbach C, Eigentler TK et al (2011) A first prospective population-based analysis investigating the actual practice of melanoma diagnosis, treatment and follow-up. Eur J Cancer 47:1977–1989

    Article  PubMed  Google Scholar 

  48. Bafounta ML, Beauchet A, Chagnon S, Saiag P (2004) Ultrasonography or palpation for detection of melanoma nodal invasion: a meta-analysis. Lancet Oncol 5:673–680

    Article  PubMed  Google Scholar 

  49. Balch CM, Gershenwald JE, Soong SJ et al (2010) Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases. J Clin Oncol 28:2452–2459

    Article  PubMed  Google Scholar 

  50. Curti BD, Urba WJ (2012) Integrating new therapies in the treatment of advanced melanoma. Curr Treat Options Oncol 13:327–339

    Google Scholar 

  51. Flaherty KT, Robert C, Hersey P et al (2012) Improved survival with MEK inhibition in BRAF-mutated melanoma. N Engl J Med 367:107–114

    Article  PubMed  CAS  Google Scholar 

  52. Robert C, Thomas L, Bondarenko I et al (2011) Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N Engl J Med 364:2517–2526

    Article  PubMed  CAS  Google Scholar 

  53. Digonnet A, Hamoir M, Andry G et al (2012) Post-therapeutic surveillance strategies in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol [Epub ahead of print]

  54. Kwa RE, Campana K, Moy RL (1992) Biology of cutaneous squamous cell carcinoma. J Am Acad Dermatol 26:1–26

    Article  PubMed  CAS  Google Scholar 

  55. Vauterin TJ, Veness MJ, Morgan GJ, Poulsen MG, O’Brien CJ (2006) Patterns of lymph node spread of cutaneous squamous cell carcinoma of the head and neck. Head Neck 28:785–791

    Article  PubMed  Google Scholar 

  56. Kyrgidis A, Tzellos TG, Kechagias N et al (2010) Cutaneous squamous cell carcinoma (SCC) of the head and neck: risk factors of overall and recurrence-free survival. Eur J Cancer 46:1563–1572

    Article  PubMed  Google Scholar 

  57. Palme CE, MacKay SG, Kalnins I, Morgan GJ, Veness MJ (2007) The need for a better prognostic staging system in patients with metastatic cutaneous squamous cell carcinoma of the head and neck. Curr Opin Otolaryngol Head Neck Surg 15:103–106

    Article  PubMed  Google Scholar 

  58. Ch’ng S, Clark JR, Brunner M, Palme CE, Morgan GJ, Veness MJ (2012) Relevance of the primary lesion in the prognosis of metastatic cutaneous squamous cell carcinoma. Head Neck [Epub ahead of print]

  59. Ebrahimi A, Moncrieff MD, Clark JR et al (2010) Predicting the pattern of regional metastases from cutaneous squamous cell carcinoma of the head and neck based on location of the primary. Head Neck 32:1288–1294

    Article  PubMed  Google Scholar 

  60. Kelder W, Ebrahimi A, Forest VI, Gao K, Murali R, Clark JR (2012) Cutaneous head and neck squamous cell carcinoma with regional metastases: the prognostic importance of soft tissue metastases and extranodal spread. Ann Surg Oncol 19:274–279

    Article  PubMed  Google Scholar 

  61. Maubec E, Petrow P, Scheer-Senyarich I et al (2011) Phase II study of cetuximab as first-line single-drug therapy in patients with unresectable squamous cell carcinoma of the skin. J Clin Oncol 29:3419–3426

    Article  PubMed  CAS  Google Scholar 

  62. Chen J, Ruczinski I, Jorgensen TJ et al (2008) Nonmelanoma skin cancer and risk for subsequent malignancy. J Natl Cancer Inst 100:1215–1222

    Article  PubMed  Google Scholar 

  63. Franchi A, Santucci M, Wenig BM (2005) Adenocarcinoma. Tumours of the nasal cavity and paranasal sinuses. In: Barnes L, Eveson JW, Reichardt P, Sidransky D (eds) World Health Organization classification of tumours. Pathology and genetics of head and neck tumours. IARC Press, Lyon, pp 20–23

  64. Leivo I (2007) Update on sinonasal adenocarcinoma: classification and advances in immunophenotype and molecular genetic make-up. Head Neck Pathol 1:38–43

    Article  PubMed  Google Scholar 

  65. Lund VJ, Chisholm EJ, Takes RP et al (2012) Evidence for treatment strategies in sinonasal adenocarcinoma. Head Neck 34:1168–1178

    Article  PubMed  Google Scholar 

  66. Choussy O, Ferron C, Védrine PO et al (2008) Adenocarcinoma of ethmoid: a GETTEC retrospective multicenter study of 418 cases. Laryngoscope 118:437–443

    Article  PubMed  Google Scholar 

  67. Allen MW, Schwartz DL, Rana V et al (2008) Long-term radiotherapy outcomes for nasal cavity and septal cancers. Int J Radiat Oncol Biol Phys 71:401–406

    Article  PubMed  Google Scholar 

  68. Van Gerven L, Jorissen M, Nuyts S, Hermans R, Vander Poorten V (2011) Long-term follow-up of 44 patients with adenocarcinoma of the nasal cavity and sinuses primarily treated with endoscopic resection followed by radiotherapy. Head Neck 33:898–904

    Article  PubMed  Google Scholar 

  69. Lund VJ, Stammberger H, Nicolai P et al (2010) European position paper on endoscopic management of tumours of the nose, paranasal sinuses and skull base. Rhinol Suppl 1:1–143

    Google Scholar 

  70. Acheson ED, Hadfield EH, Macbeth RG (1967) Carcinoma of the nasal cavity and accessory sinuses in woodworkers. Lancet 1:311–312

    Article  PubMed  CAS  Google Scholar 

  71. Sasaki M, Eida S, Sumi M, Nakamura T (2011) Apparent diffusion coefficient mapping for sinonasal diseases: differentiation of benign and malignant lesions. AJNR Am J Neuroradiol 32:1100–1106

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Head and Neck and Thoracic Surgery, Institute Jules Bordet, Brussels, Belgium

    Antoine Digonnet & Guy Andry

  2. Department of Head and Neck Surgery, St. Luc University Hospital and Cancer Center, Brussels, Belgium

    Marc Hamoir

  3. Department of Otorhinolaryngology-Head and Neck Surgery and Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium

    Vincent Vander Poorten

  4. Department of Medicine, Division of Oncology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY, USA

    Missak Haigentz Jr.

  5. Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

    Johannes A. Langendijk

  6. Department of Otolaryngology-Head and Neck Surgery, VU University Medical Center, Amsterdam, The Netherlands

    Remco de Bree

  7. Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Phoenix, AZ, USA

    Michael L. Hinni

  8. Department of Radiation Oncology, University of Florida, Gainesville, FL, USA

    William M. Mendenhall

  9. Department of Otolaryngology-Head and Neck Surgery, Newcastle upon Tyne Foundation Hospitals NHS Trust, Newcastle upon Tyne, UK

    Vinidh Paleri

  10. ENT Clinic, University of Udine, Piazzale S. Maria della Misericordia, 33100, Udine, Italy

    Alessandra Rinaldo & Alfio Ferlito

  11. Department of Otolaryngology-Head and Neck Surgery, Philipp University, Marburg, Germany

    Jochen A. Werner

  12. Department of Otolaryngology-Head and Neck Surgery, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands

    Robert P. Takes

Authors
  1. Antoine Digonnet
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marc Hamoir
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Guy Andry
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Vincent Vander Poorten
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Missak Haigentz Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Johannes A. Langendijk
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Remco de Bree
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Michael L. Hinni
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. William M. Mendenhall
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Vinidh Paleri
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Alessandra Rinaldo
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Jochen A. Werner
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Robert P. Takes
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Alfio Ferlito
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alfio Ferlito.

Additional information

This paper was written by members and invitees of the International Head and Neck Scientific Group (http://www.IHNSG.com).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Digonnet, A., Hamoir, M., Andry, G. et al. Follow-up strategies in head and neck cancer other than upper aerodigestive tract squamous cell carcinoma. Eur Arch Otorhinolaryngol 270, 1981–1989 (2013). https://doi.org/10.1007/s00405-012-2220-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-012-2220-3

Keywords

Search

Navigation